Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEXUS namilumab dose-finding study in rheumatoid arthritis
2013-002805-76Phase 2Completed
- Sponsor
- Takeda
- Start
- Dec 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of namilumab in rheumatoid arthritis (RA) (4 arms), sponsored by Takeda. Started Dec 2013; status: completed.
02
Drugs
namilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2013-002805-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002805-76.